Abstract
Background Intimate partner violence (IPV) remains a significant public health issue in Mozambique. This study uses data from the 2022-2023 Mozambique Demographic and Health Survey (DHS) to examine the prevalence and sociodemographic determinants of Lifetime IPV among women.
Methods A nationally representative sample of 4,813 women aged 15-49 was analyzed to assess the prevalence of Lifetime IPV. Logistic regression models were used to identify individual- and contextual-level factors associated with Lifetime IPV.
Results Nearly 1 in 4 women (23.07%) reported experiencing physical abuse from a current or former partner in their lifetime. Marital status emerged as a key individual-level determinant, with married, cohabitating, and separated women being at significantly higher odds of experiencing IPV compared to women who had never been in a union. Educational attainment and current employment were also associated with increased odds of IPV. Similarly, women who justified physical abuse had higher odds of experiencing IPV. Additionally, husbands/partners’ alcohol consumption was one of the strongest predictors, nearly tripling the odds of Lifetime IPV. Finally, the effect modification between marital status and education showed that the intersection of these factors further shaped IPV risk. At the contextual level, provincial disparities were observed, with Cabo Delgado and Manica showing the highest IPV prevalence, while Inhambane and Gaza had the lowest.
Conclusion This study provides updated data on the prevalence of Lifetime IPV in Mozambique and highlights key individual and contextual factors contributing to IPV. The findings underscore the need for targeted interventions addressing socio-cultural norms, improving educational opportunities, mitigating alcohol consumption, and implementing province-specific strategies to reduce IPV and enhance women’s safety across Mozambique.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Analyses within this manuscript are based on publicly available Demographic and Health Survey (DHS) data hence did not require any IRB oversight
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
